Press Releases

« Back to all press releases

Medical Research Leaders, Innovators and Investors Come to New York to Forge Partnerships, Speed Cures

WASHINGTON, DC--(Marketwired - Nov 5, 2014) - On Nov. 16-18, nearly 1,000 medical research leaders, investors and decision-makers will come to New York City for the 6th annual Partnering for Cures meeting. Convened by FasterCures, a Washington-based center of the Milken Institute, this unique conference brings together innovators from across all sectors of the medical research enterprise -- academic scientists, federal policymakers, biotechnology and pharmaceutical executives, life science investors, foundations and patients -- to forge the partnerships needed to speed the path of promising discoveries from lab to patient.

"There are so many positive changes underway that are driving us towards a more open, collaborative, patient-driven system," said Margaret Anderson, executive director of FasterCures. "But there is also a vast to-do list to accept this change and advance it. That's what Partnering for Cures is all about -- breaking down the barriers that stand in the way of medical progress and working together to reduce the time and cost of R&D."

Partnering for Cures combines the outcomes-oriented approach of investor conferences with the networking environment of industry partnering meetings. It helps attendees find solutions to some of the thorniest challenges in medical research. Topics include: 

  • Putting patients in patient-centeredness, not just in word but in deed
  • The future of U.S. research leadership
  • Redefining the impact of biomedical research investments
  • The price of innovation: Who defines 'value'?
  • The blurring boundary between university and marketplace
  • And many more 

Speakers include: 

  • Anna Barker, Professor and Director, Transformative Healthcare Networks; Co-Director, Complex Adaptive Systems Network, Arizona State University
  • ShaAvhrée Buckman-Garner, Director, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Atul Butte, Chief of the Division of Systems Medicine and Associate Professor of Pediatrics, Medicine, and Computer Science, Stanford University
  • Francis Collins, Director, National Institutes of Health
  • Meryl Comer, President, Geoffrey Beene Foundation Alzheimer's Initiative; Founder, WomenAgainstAlzheimers
  • The Honorable Diana DeGette, Chief Deputy Whip, U.S. House of Representatives
  • Deborah Dunsire, President & CEO, FORUM Pharmaceuticals
  • Esther Dyson, Founder, HICCup
  • Ilan Ganot, Founder and CEO, Solid Ventures
  • Kathy Giusti, Founder and Executive Chairwoman, Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
  • Laurie Glimcher, Dean, Weill Cornell Medical College
  • Michel Goldman, Director, Innovative Medicines Initiative
  • Allan Jones, CEO, Allen Institute for Brain Science
  • Michael Kolodziej, National Medical Director, Oncology Solutions, Office of the Chief Medical Officer, Aetna
  • Craig Lipset, Head, Clinical Innovation, Worldwide Research & Development, Pfizer Inc.
  • Eric Minikel and Sonia Vallabh, Co-Directors, Prion Alliance
  • Richard Pops, Chairman and CEO, Alkermes
  • Katherine Priestley, Managing Partner, Park Vale Capital
  • Melinda Richter, Head, Janssen Labs, Johnson & Johnson
  • Benjamin Seet, Executive Director, Biomedical Research Council, A*STAR
  • The Honorable Fred Upton, Chairman, Committee on Energy and Commerce, U.S. House of Representatives
  • Pascale Witz, Executive Vice President, Global Divisions & Strategic Development, Sanofi
  • And many more. 

In a new addition to the Partnering for Cures agenda, top entrepreneurs will describe how their mobile/digital health technology applications will increase patient participation in biomedical R&D. Moderated by a panel of experts representing entrepreneurship, drug development, clinical care, and disease philanthropy, Entrepreneurs for Cures will position three innovators with transformative products before a cross-sector audience ready to change the R&D paradigm. 

Held at the Grand Hyatt New York, Partnering for Cures is open to the public and to registered media. For registration information, go to Members of the press may apply here to receive complimentary registration.

Complete information about Partnering for Cures, including a full program and a list of speakers confirmed to date, is available at

About FasterCures
FasterCures, a center of the Milken Institute, is an action tank, determined to remove barriers to medical progress. We have only one goal: to save lives by speeding up and improving the medical research system., @FasterCures